We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-14 of 14 results
  1. Hormone Relaxin as Biomarker for Bone Health and Disease

    Bone homeostasis is maintained by fine-tuning of the dynamic balance between bone resorption via osteoclasts and bone formation via osteoblasts. Bone...
    Yukiho Kobayashi, Carolina Duarte, Keiji Moriyama in Biomarkers in Bone Disease
    Reference work entry 2017
  2. Targeting sphingosine-1-phosphate lyase as an anabolic therapy for bone loss

    Sphingosine-1-phosphate (S1P) signaling influences bone metabolism, but its therapeutic potential in bone disorders has remained unexplored. We show...

    Sarah Weske, Mithila Vaidya, ... Bodo Levkau in Nature Medicine
    Article 16 April 2018
  3. Biochemical Markers of Bone Turnover

    The use of clinically relevant biomarkers provides an important noninvasive, sensitive, rapid, and real-time tool to monitor bone activity at the...
    Susan Y. Smith, Rana Samadfam in Bone Toxicology
    Chapter 2017
  4. Effect of Statins on Bone Turnover Markers

    The link between statins, the most prescribed drugs worldwide, and the bone remodeling process have been recently suggested. Thus, there is growing...
    Magdalena Fernández García, José L. Hernández in Biomarkers in Bone Disease
    Reference work entry 2017
  5. Chitinases as Biomarkers in Bone Studies

    Despite the hardness and strength characteristic, the bone is not a static tissue, but is constantly changing and constantly repairing. This process...
    Michelino Di Rosa, Lucia Malaguarnera in Biomarkers in Bone Disease
    Reference work entry 2017
  6. Concurrent antitumor and bone-protective effects of everolimus in osteotropic breast cancer

    Background

    The mammalian target of rapamycin inhibitor everolimus is approved as an antitumor agent in advanced estrogen receptor-positive breast...

    Andrew J. Browne, Marie L. Kubasch, ... Tilman D. Rachner in Breast Cancer Research
    Article Open access 09 August 2017
  7. Hormone Relaxin as Biomarker for Bone Health and Disease

    Bone homeostasis is maintained by fine-tuning of the dynamic balance between bone resorption via osteoclasts and bone formation via osteoblasts. Bone...
    Yukiho Kobayashi, Carolina Duarte, Keiji Moriyama in Biomarkers in Bone Disease
    Living reference work entry 2015
  8. Effect of Statins on Bone Turnover Markers

    The link between statins, the most prescribed drugs worldwide, and the bone remodeling process have been recently suggested. Thus, there is growing...
    Magdalena Fernández García, José L. Hernández in Biomarkers in Bone Disease
    Living reference work entry 2015
  9. Chitinases as Biomarkers in Bone Studies

    Despite the hardness and strength characteristic, the bone is not a static tissue, but is constantly changing and constantly repairing. This process...
    Michelino Di Rosa, Lucia Malaguarnera in Biomarkers in Bone Disease
    Living reference work entry 2015
  10. Bone Biomarkers in Research and Clinical Practice

    Biomarkers as tools for aiding diagnosis, for identifying patients at risk, for monitoring response to therapy and for use as surrogate end points in...
    Janet E. Brown, Liang Zeng, Caroline Wilson in Bone Metastases
    Chapter 2014
  11. C

    Axel M. Gressner, Torsten Arndt in Lexikon der Medizinischen Laboratoriumsdiagnostik
    Chapter 2013
  12. Comparison of the effects of cholecalciferol and calcitriol on calcium metabolism and bone turnover in Chinese postmenopausal women with vitamin D insufficiency

    Aim:

    To compare the effects of cholecalciferol (800 IU/d) and calcitriol (0.25 μg/d) on calcium metabolism and bone turnover in Chinese postmenopausal...

    Hao Zhang, Qi-ren Huang, ... Zhen-lin Zhang in Acta Pharmacologica Sinica
    Article 12 March 2012
  13. Breast cancer patients with bone metastases are characterised by increased levels of nonisomerised type I collagen fragments

    Background

    Fragments of collagen type I containing the epitope AHDGGR (CTX) are generated during bone resorption. The aspartyl-glycine (DG) site...

    Paul Andreas Compare Cloos, Stephan Christgau, ... Claus Christiansen in Breast Cancer Research
    Article 01 August 2003
  14. Markers of bone turnover for the management of patients with bone metastases from prostate cancer

    Although increased bone formation is a prominent feature of patients with osteosclerotic metastases from prostate cancer, there is also some evidence...

    P Garnero, N Buchs, ... P D Delmas in British Journal of Cancer
    Article Open access 20 January 2000
Did you find what you were looking for? Share feedback.